FINAL PROGRAM www.essm.org 10th Congress of the European ...
FINAL PROGRAM www.essm.org 10th Congress of the European ...
FINAL PROGRAM www.essm.org 10th Congress of the European ...
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
poster presentationsPP-06-241Ourcomes <strong>of</strong> combined <strong>the</strong>raphy <strong>of</strong>electromotive drug administrationand colchine in peyronie diseaseMehmet Lütfü Tahmaz, TurkeyH. C. Irkilata, I. Yildrim S. Basal, M.DayancPP-06-242 Cavernous venous dysfunction,cause <strong>of</strong> erectile failure, in penilefibrosisRiccardo Vaccari, ItalyF. PezzoniPP-06-243PP-07HormonesP-07-245PP-07-246Dorsal Nesbit corporoplasty procedureand relaxing scrotoplasty forcomplex penoscrotal deformitycurvature after skin urethroplastyAhmad Shamsodini, QuatarA. Al Naimi, O. Sedigh, S. Said,A. Al AnsariPoster PresentationsHemochromatosis, a rare cause <strong>of</strong>hypogonadism - clinical caseVitor Cavadas, PortugalR. B<strong>org</strong>es, P. Masso, F. Vila, L. Osorio,N. Louro, M. Silva-Ramos, L. F. Carvalho,F. MarcelEffect <strong>of</strong> hyperprolactinemia inmale patients consulting for sexualdysfunctionGiovanni Corona, ItalyE. Mannucci, A. D. Fisher, F. Lotti,V. Ricca, G. Balercia, L. Petrone,G. Forti, M. MaggiPP-07-247 Should hormone replacementmimic normal chronobiology?Claudia Mattern, SwitzerlandM. DiverPP-07-248Efficacy <strong>of</strong> long-term injectabletestosterone undecanoate in lateonset hypogonadism patients for54 weeks follow-upDu Geon Moon, Republic <strong>of</strong> KoreaJ. W. YuPP-07-249PP-07-250PP-07-251PP-07-252PP-07-253PP-07-254PP-07-255The efficacy and safety <strong>of</strong> longactinginjectable testosteroneundecanoate (Nebido) in late onsethypogonadism patients: A Koreanmulticenter prospective studyDu Geon Moon, Republic <strong>of</strong> KoreaJ. K. Park, K. S. Park, S. W. Kim,N. C. Park, J. S. Paik, J. T. Seo, T. Y. Ahn,D. Y. Yang, S. W. Lee, J. J. KimVariation <strong>of</strong> male serum estradiol(E) after administration <strong>of</strong> morphinecloridrate (MC)Giandomenico Passavanti, ItalyV. Pizzuti, A. Aloisi, M. Carlucci,A. Bragaglia, F. Mengoni, R. PaoliniComparative study <strong>of</strong> androgensserum levels in hypogonadal mentreated with transdermal or oralpreparations <strong>of</strong> testosteroneMichele Pujos-Gautraud, FranceM. Colle, A. Lemaire, F. Giton,J.-P. RaynaudEffects <strong>of</strong> oral versus transdermaltestosterone treatment in hypogonadalmen on SHBG, LH, FSH,and AMS scoresMichele Pujos-Gautraud, FranceM. Colle, A. Lemaire, J.-P. RaynaudEfficacy and safety <strong>of</strong> a newtestosterone-in-adhesive matrixpatch applied every two days forone year to hypogonadal menJean-Pierre Raynaud, FrancePharmacokinetic study <strong>of</strong> a noveltestosterone-in-adhesive matrixpatch during <strong>the</strong> 48 hours <strong>of</strong>application to hypogonadal menJean-Pierre Raynaud, France“Aging male symptoms“ questionnairein normal and complainingmenJean-Pierre Raynaud, FranceP. Igigabel, C. Born, F. Giton, J. Fiet47
Change language